Last reviewed · How we verify
Oxycodone IR ADF — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Oxycodone IR ADF (Oxycodone IR ADF) — Grünenthal GmbH.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Oxycodone IR ADF TARGET | Oxycodone IR ADF | Grünenthal GmbH | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Oxycodone IR ADF CI watch — RSS
- Oxycodone IR ADF CI watch — Atom
- Oxycodone IR ADF CI watch — JSON
- Oxycodone IR ADF alone — RSS
Cite this brief
Drug Landscape (2026). Oxycodone IR ADF — Competitive Intelligence Brief. https://druglandscape.com/ci/oxycodone-ir-adf. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab